The largest database of trusted experimental protocols

Multitest cd3 fitc cd16 pe cd56 pe cd45 percp cd19 apc reagent

Manufactured by BD
Sourced in United States

The BD Multitest™ CD3-FITC/CD16-PE+CD56-PE/CD45-PerCP/CD19-APC reagent is a laboratory product designed for immunophenotyping of human peripheral blood cells. It contains a combination of fluorescently-labeled monoclonal antibodies that can be used to identify and enumerate specific lymphocyte subsets, including T cells, natural killer cells, and B cells, through flow cytometry analysis.

Automatically generated - may contain errors

3 protocols using multitest cd3 fitc cd16 pe cd56 pe cd45 percp cd19 apc reagent

1

Immunophenotyping of OSCC Patients' Blood

Check if the same lab product or an alternative is used in the 5 most similar protocols
The T/B/NK cells data in preoperative blood of primary OSCC patients was immediately collected and analyzed using flow cytometry. To identify and determine the percentages of mature human lymphocyte subsets in erythrocyte-lysed whole blood, including T cells (CD3+), B cells (CD19+), helper/inducer T cells (CD3+CD4+), suppressor/cytotoxic T cells (CD3+CD8+), and natural killer (NK) lymphocytes (CD3CD16+ and/or CD56+), BD Multitest™ CD3-FITC/CD8-PE/CD45-PerCP/CD4-APC reagent and BD Multitest™ CD3-FITC/CD16-PE+CD56-PE/CD45-PerCP/CD19-APC reagent were used according to the manufacturer’s instructions (Cat No. 340503, BD Biosciences, Franklin Lakes, NJ, USA), and samples were then quantified by flow cytometry on a FACS Calibur instrument. To determine the absolute counts of the lymphocyte subsets listed above, the total numbers of preoperative peripheral lymphocytes determined by the Automated Haematology Analyser XS Series (XS-1000i, Sysmex Corporation, Japan) were collected from the clinical laboratory. Since both tests came from the same batch of blood samples, we ignored the possible errors caused by the use of different detection instruments. Herein, the TBNK data of 62.3% (114/183) of OSCC patients were successfully collected and the detailed characteristic data are listed in the Supplementary Table S1.
+ Open protocol
+ Expand
2

Flow Cytometric Analysis of PBMC Subtypes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood mononuclear cell (PBMC) samples were collected from patients' preoperative whole blood. For the analysis of PBMC cell subtypes, cells were collected, washed twice with phosphate‐buffered saline (PBS, Servicebio, Wuhan, PR China), and then suspended in 200‐μl PBS. BD Multitest™ CD3 FITC/CD8 PE/CD45 PerCP/CD4 APC reagent (Cat. No. 340499, BD Multitest™, San Jose, CA, USA) and BD Multitest™ CD3 FITC/CD16 PE + CD56 PE/CD45 PerCP/CD19 APC reagent (Cat. No. 340500, BD Multitest™) were used to enumerate the CD3+ T cells, CD3+ CD4+ T cells, CD3+ CD8+ T cells, CD19+ B cells, and CD56+ NK cells. This was followed by quantification using a fluorescence‐activated cell sorting Calibur instrument. All study participants provided informed consent.
+ Open protocol
+ Expand
3

PBMC Immunophenotyping by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the cell subtypes of PBMC analysis, cells were collected and washed with PBS twice and then suspended in 200 μL PBS. For enumeration of mature human T (CD3+) cells, helper/inducer T (CD3+ CD4+) cells, cytotoxic T (CD3+ CD8+) cells, B (CD19+) cells, and NK (CD3CD16+and/orCD56+) lymphocytes, CD3FITC/CD8PE/CD45PerCP/CD4APC reagent, BD Multitest CD3FITC/CD16PE+ CD56PE/CD45PerCP/CD19APC reagent were used according to the manufacturer’s instructions, respectively (Cat No.340503, BD Multitest™), then quantified by flow cytometry on a FACS Calibur instrument.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!